Agnieszka Sekula
Agnieszka is a scientist with a background in biomedical engineering, psychology and design. She is currently a PhD candidate at Clinical Psychedelic Lab at Monash University and a co-investigator on a psilocybin study for depression, with the goal to improve outcomes and increase access through a personalised, tech-supported design of PAT. As a scientist at Monash, she investigates mechanisms of novel therapeutics, including psychedelics and VR. As a co-founder of Enosis Therapeutics she developed a novel method of leveraging immersive technology to create an insight-focused approach to mental health treatment, well-being and human optimisation. She conducted the World’s first study on using an immersive therapeutic approach in combination with psychedelics to sustain psycho-emotional change.
Agnieszka has over a decade of experience in science innovation using cutting edge biotech tools, including customised imaging robots, 3D modelling and VR. Her work has led her to innovate medical research all over the world, including forensic medicine in Switzerland, space medicine in Austria and translational science in Singapore.
She is devoted to science outreach, extensively advocating for open-science communication, community led research and outcome transparency, with extensive experience in public speaking and teaching to science and non-science audiences. Her designs have been displayed worldwide, including Shanghai EXPO, Florence Biennale or Austrian Sounds of Space. Her work has been featured in ABC Australia, BBC Science, Mashable and Bloomberg and she produced freelance journaling articles for Psychiatric Times and Przekroj Magazine.
